Clinical Trial Update: Bilastine Updosing in Chronic Spontaneous Urticaria [Phase 3]

View source ↗

Summary

Phase 3 trial update on bilastine dosing for chronic spontaneous urticaria; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Urticaria

Drugs mentioned

• Bilastine (bilastine)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Chronic Urticaria | Phase 3 | Status: COMPLETED